Vascular Biology |
From the Center for Molecular and Vascular Biology (H.R.L., B.V.H., I.V., M.V., D.C.), University of Leuven, Leuven, Belgium; and CNRS-INSERM-ULP (M.-C.R.), Illkirch, France.
Correspondence to H. R. Lijnen, Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, O & N, Herestraat 49, B-3000 Leuven, Belgium. E-mail: roger.lijnen{at}med.kuleuven.ac.be
AbstractThe hypothesis that
stromelysin-3 (MMP-11), a unique member of the matrix metalloproteinase
(MMP) family, plays a role in neointima formation was
tested with the use of a vascular injury model in wild-type
(MMP-11+/+) and MMP-11deficient (MMP-11-/-)
mice. Neointima formation 2 to 3 weeks after electric
injury of the femoral artery was significantly enhanced in
MMP-11-/- as compared with MMP-11+/+ mice, in
both mice of a pure 129SV genetic background (0.014 versus 0.0010
mm2 at 2 weeks, P<0.001) and those of a
50/50 mixed 129SV/BL6 background (0.030 versus 0.013
mm2 at 3 weeks, P<0.05). The medial areas
were comparable, resulting in intima/media ratios that were
significantly increased in MMP-11-/- as compared with
MMP-11+/+ arteries, in mice of both the 129SV (1.0 versus
0.18, P<0.001) and mixed (1.5 versus 0.70,
P<0.05) backgrounds. Nuclear cell counts in
cross-sectional areas of the intima of the injured region were higher
in arteries from MMP-11-/- mice than in those from
MMP-11+/+ mice (210 versus 48, P<0.001, in
pure 129SV mice and 290 versus 150, P<0.01, in mice of
the mixed genetic background). Immunocytochemical analysis
revealed that
-actinpositive and CD45-positive cells were more
abundant in intimal sections of MMP-11-/- mice.
Degradation of the internal elastic lamina was more extensive in
arteries of MMP-11-/- mice than in those of
MMP-11+/+ mice (39% versus 6.8% at 3 weeks,
P<0.005). The mechanisms by which MMP-11 could impair
elastin degradation and cellular migration in this model remain,
however, unknown.
Key Words: neointima restenosis transgenic mice stromelysin-3
This article has been cited by other articles:
![]() |
K. Imai, S. S. Dalal, J. Hambor, P. Mitchell, Y. Okada, W. C. Horton, and J. D'Armiento Bone growth retardation in mouse embryos expressing human collagenase 1 Am J Physiol Cell Physiol, October 1, 2007; 293(4): C1209 - C1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Nakopoulou, A. C. Lazaris, I. Boletis, S. Michail, C. Iatrou, G. Papadakis, S. Athanassiadou, and C. Stathakis The expression of matrix metalloproteinase-11 protein in various types of glomerulonephritis Nephrol. Dial. Transplant., January 1, 2007; 22(1): 109 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Janssens and H. R. Lijnen What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models? Cardiovasc Res, February 15, 2006; 69(3): 585 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P.G. Sluijter, D. P.V. de Kleijn, and G. Pasterkamp Vascular remodeling and protease inhibition-bench to bedside Cardiovasc Res, February 15, 2006; 69(3): 595 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Spencer, S. L. Hacker, E. C. Davis, R. P. Mecham, R. H. Knutsen, D. Y. Li, R. D. Gerard, J. A. Richardson, E. N. Olson, and H. Yanagisawa Altered vascular remodeling in fibulin-5-deficient mice reveals a role of fibulin-5 in smooth muscle cell proliferation and migration PNAS, February 22, 2005; 102(8): 2946 - 2951. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Newby Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque Rupture Physiol Rev, January 1, 2005; 85(1): 1 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Myers and L. Liaw Improved Analysis of the Vascular Response to Arterial Ligation Using a Multivariate Approach Am. J. Pathol., January 1, 2004; 164(1): 43 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cho and M. A. Reidy Matrix Metalloproteinase-9 Is Necessary for the Regulation of Smooth Muscle Cell Replication and Migration After Arterial Injury Circ. Res., November 1, 2002; 91(9): 845 - 851. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |